Literature DB >> 399884

Cellular mechanisms of proteinase release from inflammatory cells and the degradation of extracellular proteins.

M Baggiolini, J Schnyder, U Bretz, B Dewald, W Ruch.   

Abstract

Neutrophils and macrophages produce, store and release large amounts of various acid and neutral proteinases. The two main proteinases of neutrophils are elastase and cathepsin G. They are localized in the azurophil granules, together with proteinase 3 and the acid cathepsins B and D. In addition neutrophils contain collagenase in the specific granules, acid proteinases in the C-particles and plasminogen activator in organelles with the characteristics of secretory vesicles. The granule-bound proteinases are released during phagocytosis while plasminogen activator is apparently secreted. In macrophages, the acid hydrolases are bound to lysosomes while the neutral proteinases are confined to secretory vesicles. The main mechanism of enzyme release in macrophages is secretion. Lysosomal hydrolases are also released by phagocytosis. Enzyme secretion is a characteristic property of activated or inflammatory macrophages. Macrophages become activated after phagocytosis of certain particles and the metabolic burst appears to be an initial event in the activation process. The action of neutrophils and of purified elastase or plasmin on cartilage was tested. These experiments indicate that neutrophil-mediated degradation of cartilage proteoglycans is largely dependent on elastase.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 399884     DOI: 10.1002/9780470720585.ch7

Source DB:  PubMed          Journal:  Ciba Found Symp        ISSN: 0300-5208


  10 in total

Review 1.  Phagocytes use oxygen to kill bacteria.

Authors:  M Baggiolini
Journal:  Experientia       Date:  1984-09-15

2.  The 1.8 A crystal structure of human cathepsin G in complex with Suc-Val-Pro-PheP-(OPh)2: a Janus-faced proteinase with two opposite specificities.

Authors:  P Hof; I Mayr; R Huber; E Korzus; J Potempa; J Travis; J C Powers; W Bode
Journal:  EMBO J       Date:  1996-10-15       Impact factor: 11.598

Review 3.  Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils.

Authors:  M Baggiolini; A Walz; S L Kunkel
Journal:  J Clin Invest       Date:  1989-10       Impact factor: 14.808

4.  Rebamipide, an antiulcer drug, prevents DSS-induced colitis formation in rats.

Authors:  S Kishimoto; K Haruma; A Tari; K Sakurai; M Nakano; Y Nakagawa
Journal:  Dig Dis Sci       Date:  2000-08       Impact factor: 3.199

5.  Expression of interleukin-8 gene in inflammatory bowel disease is related to the histological grade of active inflammation.

Authors:  L Mazzucchelli; C Hauser; K Zgraggen; H Wagner; M Hess; J A Laissue; C Mueller
Journal:  Am J Pathol       Date:  1994-05       Impact factor: 4.307

6.  Enzymatic activities of bovine peripheral blood leukocytes and milk polymorphonuclear neutrophils during intramammary inflammation caused by lipopolysaccharide.

Authors:  C Prin-Mathieu; Y Le Roux; G C Faure; F Laurent; M C Béné; F Moussaoui
Journal:  Clin Diagn Lab Immunol       Date:  2002-07

7.  Oxidative regulation of neutrophil elastase-alpha-1-proteinase inhibitor interactions.

Authors:  P J Ossanna; S T Test; N R Matheson; S Regiani; S J Weiss
Journal:  J Clin Invest       Date:  1986-06       Impact factor: 14.808

8.  Enhanced production of neutrophil-activating peptide-1/interleukin-8 in rheumatoid arthritis.

Authors:  M Seitz; B Dewald; N Gerber; M Baggiolini
Journal:  J Clin Invest       Date:  1991-02       Impact factor: 14.808

Review 9.  Cathepsin G: roles in antigen presentation and beyond.

Authors:  Timo Burster; Henriette Macmillan; Tieying Hou; Bernhard O Boehm; Elizabeth D Mellins
Journal:  Mol Immunol       Date:  2009-11-11       Impact factor: 4.407

10.  Pericellular proteolysis by neutrophils in the presence of proteinase inhibitors: effects of substrate opsonization.

Authors:  E J Campbell; M A Campbell
Journal:  J Cell Biol       Date:  1988-03       Impact factor: 10.539

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.